Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein

J Clin Lipidol. Sep-Oct 2010;4(5):382-8. doi: 10.1016/j.jacl.2010.08.007.

Abstract

High-density lipoprotein (HDL) has many protective activities against atherosclerosis, including its role in reverse cholesterol transport, and its antioxidant, anti-inflammatory, and endothelial cell maintenance functions. However, all HDL is not functionally equivalent. The authors of recent studies have shown that infection, inflammation, diabetes, and coronary artery disease are associated with dysfunctional HDL. HDL can lose its protective activities through a variety of mechanisms, including, but not limited to, altered protein composition, oxidative protein modification mediated by the enzyme myeloperoxidase, and lipid modification. Studies in which the authors used bacterial endotoxin in humans and mice have directly demonstrated changes in HDL composition, loss of HDL's cholesterol acceptor activity, and decreased hepatic processing and secretion of cholesterol. Although a routine clinical assay for dysfunctional HDL is not currently available, the development of such an assay would be beneficial for a better understanding of the role that dysfunctional HDL plays as a risk factor for coronary artery disease and for the determination of how various drug therapies effect HDL functionality.

Keywords: Reverse cholesterol transport; apolipoprotein A-I; cholesterol efflux; high density lipoprotein; inflammation; lipopolysaccharide.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apolipoprotein A-I / metabolism
  • Coronary Artery Disease / etiology
  • Disease Models, Animal
  • Humans
  • Inflammation / metabolism*
  • Lipoproteins, HDL / metabolism
  • Lipoproteins, HDL / physiology*
  • Mice
  • Oxidation-Reduction
  • Peroxidase / metabolism*
  • Risk Factors

Substances

  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • Peroxidase